Related Experiment Video
Updated: Apr 28, 2026

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
Published on: February 28, 2020
The impact of tumor stroma on drug response in breast cancer
Jürgen Dittmer1, Benjamin Leyh1
1Clinic for Gynecology, University of Halle, Halle/Saale, Germany.
Abstract:
In the last two decades the breast cancer mortality rate has steadily declined, in part, due to the availability of better treatment options. However, drug resistance still remains a major challenge. Resistance can be an inherent feature of breast cancer cells, but can also arise from the tumor microenvironment. This review aims to focus on the modulatory effect of the tumor microenvironment on the differing response of breast cancer subtypes to targeted drugs and chemotherapy.
Insights
Drug resistance in breast cancer is a major challenge, even with improved treatments. The tumor microenvironment significantly influences how different breast cancer subtypes respond to therapies, impacting treatment effectiveness.
Area of Science:
- Oncology
- Cancer Biology
- Pharmacology
Background:
- Breast cancer mortality has decreased due to advanced treatments.
- Drug resistance remains a significant obstacle in effective breast cancer therapy.
- Resistance can be intrinsic to cancer cells or influenced by the tumor microenvironment.
Purpose of the Study:
- To review the tumor microenvironment's role in breast cancer drug resistance.
- To analyze how the tumor microenvironment affects responses to targeted drugs and chemotherapy.
- To explore differential responses across breast cancer subtypes.
Main Methods:
- Literature review of recent studies on breast cancer, tumor microenvironment, and drug resistance.
- Analysis of mechanisms by which the tumor microenvironment modulates therapeutic responses.
- Synthesis of findings related to various breast cancer subtypes.
Main Results:
- The tumor microenvironment plays a critical role in the development of drug resistance.
- Specific components of the microenvironment can promote resistance to targeted therapies and chemotherapy.
- Breast cancer subtypes exhibit varying sensitivities to drugs based on their microenvironmental interactions.
Conclusions:
- Targeting the tumor microenvironment may offer novel strategies to overcome drug resistance.
- Understanding subtype-specific microenvironmental influences is crucial for personalized breast cancer treatment.
- Further research into the tumor microenvironment is essential for improving patient outcomes.
Related Concept Videos
The Tumor Microenvironment
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Drugs that Stabilize Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers

